Global Peripheral Vascular Devices Market 2015-2019

"01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Product
07.1 Global Peripheral Vascular Stents Market
07.1.1 Market Size and Forecast
07.1.2 Market Segmentation
07.2 Global  PTA Balloon Catheters Market
07.2.1 Market Size and Forecast
07.2.2 Market Segmentation
07.3 Global Aortic Stent Grafts Market
07.3.1 Market Size and Forecast
07.3.2 Market Segmentation
07.4 Global Atherectomy Devices Market
07.4.1 Market Size and Forecast
07.4.2 Market Segmentation
07.5 Global Embolic Protection Devices Market
07.5.1 Market Size and Forecast
07.5.2 Market Segmentation
08. Global Expenditure on Medical Devices and Reimbursements
08.1.1 Expenditure on Medical Devices in Major OECD Countries 2013
08.1.2 Reimbursement Scenario
09. Geographical Segmentation
09.1 Peripheral Vascular Devices Market in Americas
09.1.1 Market Size and Forecast
09.2 Peripheral Vascular Devices Market in EMEA
09.2.1 Market Size and Forecast
09.3 Peripheral Vascular Devices Market in APAC
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and Their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and Their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Acquisitions
17.2 Vendor Analysis 2014
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Laboratories
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Business Segmentation
18.1.4 Business Strategy
18.1.5 Business Segmentation by Revenue 2012
18.1.6 Business Segmentation by Revenue 2011 and 2012
18.1.7 Geographical Segmentation by Revenue 2012
18.1.8 Key Information
18.1.9 SWOT Analysis
18.2 Boston Scientific
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Key Products
18.2.4 Key Products in Cardiovascular Segment
18.2.5 Key Products in MedSurg Segment
18.2.6 Key Products in Rhythm Management Segment
18.2.7 Business Segmentation by Revenue 2013
18.2.8 Business Segmentation by Revenue 2012 and 2013
18.2.9 Geographical Segmentation by Revenue 2013
18.2.10 Business Strategy
18.2.11 Recent Developments
18.2.12 SWOT Analysis
18.3 C. R. Bard
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Product Segmentation by Revenue 2013
18.3.4 Product Segmentation by Revenue 2012 and 2013
18.3.5 Geographical Segmentation by Revenue 2013
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Cordis
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation
18.4.4 Business Strategy
18.4.5 Recent Developments
18.4.6 SWOT Analysis
18.5 Medtronic
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Key Products
18.5.4 Business Segmentation by Revenue 2014
18.5.5 Cardiac and Vascular Group Segmentation by Revenue 2014
18.5.6 Restorative Therapies Group Segmentation by Revenue 2014
18.5.7 Diabetes Group Segmentation by Revenue 2014
18.5.8 Business Segmentation by Revenue 2013 and 2014
18.5.9 Cardiac and Vascular Group Segmentation by Revenue 2013 and 2014
18.5.10 Restorative Therapies Group Segmentation by Revenue 2013 and 2014
18.5.11 Diabetes Group Segmentation by Revenue 2013 and 2014
18.5.12 Geographical Segmentation by Revenue 2014
18.5.13 Business Strategy
18.5.14 Key Developments
18.5.15 SWOT Analysis
19. Other Reports in This Series